LABGENIUS Trademark

Trademark Overview


On Friday, December 13, 2019, a trademark application was filed for LABGENIUS with the United States Patent and Trademark Office. The USPTO has given the LABGENIUS trademark a serial number of 79277459. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by LABGENIUS LIMITED. The LABGENIUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of peptide and protein engineering; research and development in the fields of gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; research and development in the field of pharmaceuticals; research and development in the field of therapeutics; design, development and maintenance of robotic automation software in the fields of gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design, development and maintenance of software in the fields of gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design and development of pharmaceuticals using machine learning; drug development and discovery services; drug development services using machine learning; drug development services using robotic automation; scientific services for structure analysis, modification of an...
labgenius

General Information


Serial Number79277459
Word MarkLABGENIUS
Filing DateFriday, December 13, 2019
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6253510
Registration DateTuesday, January 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements


Goods and ServicesResearch and development in the field of peptide and protein engineering; research and development in the fields of gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; research and development in the field of pharmaceuticals; research and development in the field of therapeutics; design, development and maintenance of robotic automation software in the fields of gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design, development and maintenance of software in the fields of gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; design and development of pharmaceuticals using machine learning; drug development and discovery services; drug development services using machine learning; drug development services using robotic automation; scientific services for structure analysis, modification of antibodies, peptides and/or proteins; scientific services for the production of genetically-engineered antibodies, peptides and/or proteins for others, namely, scientific development services; scientific services for drug development and discovery; consulting services in the fields of biotechnology and pharmaceutical research; provision of information and data relating to research and development; scientific technical data analysis services; analysis and interpretation of scientific data using machine learning; platform as a service (PAAS) featuring computer software platforms for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development; software as a service (SAAS) services featuring software for data collection, data analytics and data interpretation, for use in the fields of therapeutics, gene synthesis, DNA sequencing, genomics, bioinformatics, protein engineering and/or drug discovery and development
Pseudo MarkLAB GENIUS

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 6, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLABGENIUS LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameLABGENIUS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameLABGENIUS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Sunday, May 23, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, April 30, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 30, 2021FINAL DISPOSITION PROCESSED
Monday, April 26, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Sunday, November 8, 2020NOTIFICATION PROCESSED BY IB
Wednesday, October 21, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 21, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 7, 2020NON-FINAL ACTION E-MAILED
Friday, August 7, 2020NON-FINAL ACTION WRITTEN
Thursday, July 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 17, 2020REFUSAL PROCESSED BY IB
Monday, March 30, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 30, 2020REFUSAL PROCESSED BY MPU
Tuesday, March 17, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 16, 2020NON-FINAL ACTION WRITTEN
Friday, March 13, 2020ASSIGNED TO EXAMINER
Tuesday, February 11, 2020APPLICATION FILING RECEIPT MAILED
Thursday, February 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 30, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB